BREAKING
Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 24 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 5 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 24 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 5 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago
ADVERTISEMENT
Market News

Main takeaways from Philip Morris’ (PM) Q2 2025 earnings report

Shares of Philip Morris International Inc. (NYSE: PM) were down over 7% on Tuesday after the company delivered mixed results for the second quarter of 2025. Revenue and earnings saw growth compared to the previous year but while the bottom line beat expectations, the top line fell short of estimates. Here are the main takeaways […]

$PM July 22, 2025 2 min read

Shares of Philip Morris International Inc. (NYSE: PM) were down over 7% on Tuesday after the company delivered mixed results for the second quarter of 2025. Revenue and earnings saw growth compared to the previous year but while the bottom line beat expectations, the top line fell short of estimates. Here are the main takeaways from the earnings report:

Mixed results

In Q2 2025, PM generated revenues of $10.1 billion, which were up 7.1% from the year-ago quarter, but below expectations of $10.3 billion. Organic revenue growth was 6.8%. GAAP earnings per share grew 26.6% year-over-year to $1.95. Adjusted EPS rose 20.1% to $1.91, surpassing estimates of $1.86.  

Business performance

PM’s smoke-free business continued its momentum in the second quarter with double-digit growth in shipments, revenue and gross profit. Shipments grew 11.8%, revenue was up 15.2%, and gross profit rose 23.3%. The company’s smoke-free products are available in 97 markets and the business accounted for 41% of net revenues in Q2.

The smoke-free portfolio is led by IQOS, which exceeded $3 billion in revenues in Q2. IQOS continued its strong growth in Japan and Europe and also gained share in markets like Jakarta, Mexico City and Seoul. Within the oral smoke-free product category, shipment volume increased by 23.8% in Q2, led by nicotine pouches. Nicotine pouches volumes grew over 40% in the US and more than doubled internationally.

Within combustibles, net revenue grew 2.1%, helped by strong pricing. Cigarettes volume dropped 1.5% in the quarter. The Marlboro brand continues to gain market share and the company’s overall cigarette category share remained broadly stable.

ADVERTISEMENT

Outlook

For the full year of 2025, PM expects organic revenue growth of 6-8%. Reported EPS is expected to be $7.24-7.37 while adjusted EPS is expected to be $7.43-7.56.

ADVERTISEMENT